Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Lung Neoplasms 22Breast Neoplasms 18Hematologic Neoplasms 17Colorectal Neoplasms 13Prostatic Neoplasms 11Neoplasms 10Carcinoma, Non-Small-Cell Lung 10Pancreatic Neoplasms 9Hematopoietic and Lymphatic System Neoplasm 8Anatomic Stage I Breast Cancer AJCC v8 8Urinary Bladder Neoplasms 6Ovarian Neoplasms 6Uterine Cervical Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Neoplasm Metastasis 5Multiple Myeloma 5Melanoma 5Head and Neck Carcinoma 5Breast Carcinoma In Situ 5Triple Negative Breast Neoplasms 4Stomach Neoplasms 4Hematopoietic and Lymphoid System Neoplasm 4Mouth Neoplasms 3Lymphoma 3Leukemia, Myeloid, Acute 3Head and Neck Neoplasms 3Esophageal Neoplasms 3Colonic Neoplasms 3Carcinoma, Renal Cell 3Carcinoma 3

Interventions

Standard of Care 2tocilizumab 1Tomography, X-Ray Computed 1Practice Guidelines as Topic 1Operative Blood Salvage 1Molecular Imaging 1Methods 1Magnetic Resonance Spectroscopy 1Interviews as Topic 1Immunoglobulin G 1High-Energy Shock Waves 1Educational Status 1Early Intervention, Educational 1Disulfides 1Cardiac Surgical Procedures 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Coronary Artery Disease × Practice Guidelines as Topic × Clear all
NCT04361552 2020-06-18

Tocilizumab for the Treatment of Cytokine Release Syndrome in Patients With COVID-19 (SARS-CoV-2 Infection)

Emory University

Phase 3 Withdrawn
Genitourinary

COVID-19, Coronary Artery Disease, Diabetes Mellitus, Kidney Failure, Chronic, Neoplasms, Stroke, Pulmonary Disease, Chronic Obstructive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡